Adenosine diphosphate-induced platelet-fibrin clot strength: A new thrombelastographic indicator of long-term poststenting ischemic events

American Heart Journal

Volumn 160, Issue 2, 2010, Pages 346-354

  Gurbel, Paul A ^a   Bliden, Kevin P ^a   Navickas, Irene A ^b   Mahla, Elizabeth ^a   Dichiara, Joseph ^a   Suarez, Thomas A ^a   Antonino, Mark J ^a   Tantry, Udaya S ^a   Cohen, Eli ^b  

^a SINAI CENTER FOR THROMBOSIS RESEARCH   (United States)

^b Haemoscope Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; CLOPIDOGREL; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; THROMBIN;

AGED; AREA UNDER THE CURVE; ARTICLE; BLEEDING; CONTROLLED STUDY; DISEASE DURATION; FEMALE; FIBRIN CLOT; HUMAN; HUMAN CELL; ISCHEMIA; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; STENT; THROMBOCYTE; THROMBOCYTE AGGREGATION; THROMBOELASTOGRAPHY;

ADENOSINE DIPHOSPHATE; HUMANS; INCIDENCE; MYOCARDIAL ISCHEMIA; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; ROC CURVE; SENSITIVITY AND SPECIFICITY; STENTS; THROMBELASTOGRAPHY;

EID: 77955447165     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2010.05.034     Document Type: Article

References (14)

1. Furie B., and Furie B.C. Thrombus formation in vivo J Clin Invest 115 2005 3355 3362
2. Lee K.W., and Lip G.Y. Acute coronary syndromes: Virchow's triad revisited Blood Coagul Fibrinolysis 14 2003 605 625
3. Gurbel P.A., Becker R.C., and Mann K.G. Platelet function monitoring in patients with coronary artery disease J Am Coll Cardiol 50 2007 1822 1834
4. Gurbel P.A., Antonino M.J., and Tantry U.S. Antiplatelet treatment of cardiovascular disease: a translational research perspective Pol Arch Med Wewn 118 2008 289 297
5. Gurbel P.A., Bliden K.P., and Guyer K. Platelet reactivity in patients and recurrent events post-stenting: results of the PREPARE POST-STENTING Study J Am Coll Cardiol 46 2005 1820 1826
6. Bliden K.P., DiChiara J., and Tantry U.S. Increased risk in patients with high platelet aggregation receiving chronic clopidogrel therapy undergoing percutaneous coronary intervention: is the current antiplatelet therapy adequate? J Am Coll Cardiol 49 2007 657 666
7. Thygesen K., Alpert J.S., and White H.D. Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction Eur Heart J 28 2007 2525 2538
8. Mauri L., Hsieh W.H., and Massaro J.M. Stent thrombosis in randomized clinical trials of drug-eluting stents N Engl J Med 356 2007 1020 1029
9. Antman E.M., Cohen M., and Bernink P.J. The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making JAMA 284 2000 835 842
10. Gurbel P.A., and Tantry U.S. The relationship of platelet reactivity to the occurrence of post-stenting ischemic events: emergence of a new cardiovascular risk factor Rev Cardiovasc Med 7 Suppl 4 2006 S20 S28
11. Gurbel P.A., Antonino M.J., and Bliden K.P. Platelet reactivity to adenosine diphosphate and long-term ischemic event occurrence following percutaneous coronary intervention: a potential antiplatelet therapeutic target Platelets 19 2008 595 604
12. Gurbel P.A., Bliden K.P., and Guyer K. Delayed thrombin-induced platelet-fibrin clot generation by clopidogrel: a new dose-related effect demonstrated by thrombelastography in patients undergoing coronary artery stenting Thromb Res 119 2007 563 570
13. McCrath D.J., Cerboni E., and Frumento R.J. Thromboelastography maximum amplitude predicts postoperative thrombotic complications including myocardial infarction Anesth Analg 100 2005 1576 1583
14. Breet N.J., van Werkum J.W., and Bouman H.J. Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation JAMA 303 2010 754 762